Mon09252023

Last updateThu, 03 Aug 2023 1pm

Back You are here: Inicio Biology & biomedicine Success stories

New biomimetic skin gels patents, developed at IQAC-CSIC, are acquired by Bicosome

Two new patents developed at the Institute of Advanced Chemistry of Catalonia (IQAC) from the CSIC have been licensed by Bicosome company. The new technological platforms made of only lipids and water do not need the presence of polymers, surfactants, or other gelling agents, bringing valuable benefits for skin care, especially sensitive skin.

Read more ...

A spin-off company will develop a monoclonal antibody to treat autoimmune diseases such as psoriasis

The antibody acts on the immune system to increase anti-inflammatory activity and attenuate inflammation. It will be developed by the Inhibitec Anticuerpos company, created by the scientists who created the technology at the CSIC and the University of Cantabria.

Read more ...

A more effective nanomedicine has been developed for the treatment of Fabry rare disease

This is one of the major achievements of the European Smart4Fabry project, which is now coming to an end after four years of work. The results have been made possible by nanotechnology and the approach developed could be applied to other drugs in the future. The new drug improves on current treatments and helps reduce costs and improve patients' quality of life.

Read more ...

Bio-nanocellulose meshes improve hernia repair surgery

Researchers from the Institute of Materials Science of Barcelona (ICMAB-CSIC) and B. Braun Surgical, a leading manufacturer of medical devices for wound closure, have collaborated to develop a bio-based surgical mesh with this biomaterial. First results from an in vivo animal study yield promising outcomes.

Read more ...

Antibodies test for Covid-19 with near 100% accuracy

A new serological test for Covid-19 with an accuracy close to 100% has been developed by researchers from the CSIC, in collaboration with the hospitals of La Princesa and La Paz. The Spanish biotechnology company Immunostep produces and commercializes the test.

Read more ...